Leadership & Pay ·
Evotec CSO Dr. Cord Dohrmann steps down effective September 30 following mutual consent
EVOEvotec SE
Evotec SE announced that Chief Scientific Officer Dr. Cord Dohrmann will step down effective September 30, 2026, following mutual consent between him and the company. Dr. Dohrmann has served as CSO and Member of the Management Board since 2010, playing a significant role in strengthening scientific excellence and establishing key capabilities across platforms including iPSC-based technologies and omics. The search for his replacement is ongoing. Evotec SE operates in the life sciences industry, pioneering drug discovery and development through integrated science, AI-driven innovation, and advanced technologies.